Christopher Viehbacher

Board Member at Stanford Medicine

Christopher Viehbacher is the Managing Partner of Gurnet Point Capital, a Boston-based investment fund associated with the Bertarelli family, and has a $2 billion capital allocation. He is the former CEO and Member of the Board of Directors of Sanofi and was also the Chairman of the Board of Genzyme in Boston. Prior to joining Sanofi, Chris spent 20 years with GlaxoSmithKline in Germany, Canada, France, and, latterly, the U.S. as President of GSK North America.